WELCOME TO
ATMPS
A Unique Patent Pending Tech Solution for ATMPs
The Management Team
Chairman
Prof Ghulam Mufti OBE
A world renowned professor in the research, diagnosis and treatment of blood cancers, who changed how blood cancers were treated internationally. Awarded an OBE in 2017, research included cell and gene therapies, over 450 papers, developing the first immune gene therapy programme, Various Chair and executive roles at Kings College Hospital and advisory positions with pharmaceutical companies and charities.
Founder and CEO
Raja Sharif
A UK qualified barrister with over 20 years of international management level experience including as director/company secretary. Working mainly as General Counsel, Director of Commercial Affairs, and Management and Strategy. Experience of multinationals include Guardian iT Plc, Globix, British Telecom PLC, COLT and Al Jazeera
CFO
Philip Cheek
Over 35 years of finance and management experience including as director of an number of UK and European companies. Philip has significant exposure to M&A activity, successful exits and fundraising activities. Managing companies across the IT spectrum, involved in formulating and executing strategy.
Business Development Director
Mike Quinn
Over 40 years management experience in the IT sector including sales and business development. He has held various director level roles in technology firms including advising venture capital firms. Has founded various start-ups and floated companies on AIM and LSE
Data Strategy Lead
Najib Rehman
Senior manager with experience in Strategy and Operations with 16 years of experience at Pfizer specialising in data gathering, data analytics and logistics management. Najib also leads various standing setting activities and manages relationships with industry partners such as CGT Catapult
CTO
Shahnawaz Aziz
Over 21 years of IT experience in managing, architecting, designing and developing software applications across various industry domains, with a demonstrated track record of leading IT project. Companies include nChain, Maersk, Tungsten Networks
Chairman
Prof Ghulam Mufti OBE
A world renowned professor in the research, diagnosis and treatment of blood cancers, who changed how blood cancers were treated internationally. Awarded an OBE in 2017, research included cell and gene therapies, over 450 papers, developing the first immune gene therapy programme, Various Chair and executive roles at Kings College Hospital and advisory positions with pharmaceutical companies and charities.
Founder and CEO
Raja Sharif
A UK qualified barrister with over 20 years of international management level experience including as director/company secretary. Working mainly as General Counsel, Director of Commercial Affairs, and Management and Strategy. Experience of multinationals include Guardian iT Plc, Globix, British Telecom PLC, COLT and Al Jazeera
​
​
CFO
Philip Cheek
Over 35 years of finance and management experience including as director of an number of UK and European companies. Philip has significant exposure to M&A activity, successful exits and fundraising activities. Managing companies across the IT spectrum, involved in formulating and executing strategy.
​
​
Business Development Director
Mike Quinn
Over 40 years management experience in the IT sector including sales and business development. He has held various director level roles in technology firms including advising venture capital firms. Has founded various start-ups and floated companies on AIM and LSE
Data Strategy Lead
Najib Rehman
Senior manager with experience in Strategy and Operations with 16 years of experience at Pfizer specialising in data gathering, data analytics and logistics management. Najib also leads various standing setting activities and manages relationships with industry partners such as CGT Catapult
CTO
Shahnawaz Aziz
Over 21 years of IT experience in managing, architecting, designing and developing software applications across various industry domains, with a demonstrated track record of leading IT project. Companies include nChain, Maersk, Tungsten Networks
Our Advisors
University Hospital Birmingham
Prof Philip Newsome
Deputy Director for the NIHR Birmingham Head of Cell Therapy at the University of Birmingham and Academic Lead for the Cell Therapy Facility, a state-of-the art manufacturing facility. Links with CGT Catapult driving innovation and translation in the field of cell therapy. Work at University Hospital Birmingham NHS Foundation
University Hospital Dresden
Prof Martin Bornhauser
Focus on translational research studies in the area of acute myeloid leukaemia and hematopoietic cell transplantation. Founding members of Center of Regenerative Therapy Dresden, expertise in the areas of stem cell biology, cellular therapy. Visiting professor at King’s College and National Center for Tumor Diseases in Dresden.
University Hospital Wales
Dr Wendy Ingram
Over 35 years of finance and management experience including as director of an number of UK and European companies. Philip has significant exposure to M&A activity, successful exits and fundraising activities. Managing companies across the IT spectrum, involved in formulating and executing strategy.
UCL – GOSH
Prof Waseem Qassim
Special interest in T lymphocytes used for new therapies. My research centre on diagnosing and treating immune disorders, haematopoietic stem cell transplantation (HSCT) and gene based therapies for leukaemia and other conditions. Lab projects are developing and testing viral vectors and gene editing reagents including TALENs and CRISPR/Cas9.
Sheffield University
Prof Moumin Azzouz
Post-doctoral scientist at the Gene Therapy Center in Lausanne, Switzerland. Currently Chair of Translational Neuroscience and Deputy Head of Department, Research/Innovation at Sheffield University. Member Panels/Boards for the Medical Research Council, French Muscular Dystrophy Association, the Health Research Board of Ireland, Research Council of Norway, and the Neuroscience Panel, Germany.
King’s College/ Anthony Nolan
Prof Tony Pagliuca
Antonio Pagliuca, Professor of Stem Cell Transplantation at King’s College London, is the Chief Medical and Scientific Advisor for the Anthony Nolan and a trustee for Leukaemia UK. lead King’s attainment to a Centre of Excellence and one of the largest unrelated, cord, haplo-identical transplant and cellular therapy programs in the UK. In 2018, King’s became the first CAR-T centre in UK
King Faisal Research Hospital
KSA
Dr Mahmoud Aljurf
Director of Adult Stem Cell Transplantation and Cell Therapy Program. Deputy Director of the Oncology Centre at King Faisal Hospital, Saudi Arabia. Residency training at Brigham Hospital, Harvard Medical School, Hematology & Oncology Fellowships at Stanford University Medical Center. Master’s in Public Health (MPH) from Johns Hopkins University. Dr. Aljurf is the Editor-in-Chief for the Elsevier journal “Hematology/Oncology and Stem Cell Therapy”.
Centre of Clinical Haematology
Singapore
Dr Zi Lim Yi
Medical Director of CFCH and a Senior Consultant in Haematology. Special interest in Haemato-oncology and Haematopoietic Stem Cell Transplantation. Fellow of the Royal College of Physicians. President of the Bone Marrow Donor Programme (BMDP) Singapore, Co-Founder and CEO CellVec Pte Ltd. Formed the Centre for Clinical Haematology 2019
Apply Today
We're always on the lookout for new team members! If you think you'd be a great asset to the team here at ATMPS, please send your CV over to info@atmps.net